Skip to main content

Table 1 Characteristics of 29 patients with AML treated with EMA-G.

From: Timed sequential chemotherapy with concomitant Granulocyte Colony-Stimulating Factor for high-risk acute myelogenous leukemia: a single arm clinical trial

Patients

29

Median Age (years)

51

Range

(25–75)

Male: Female

16:13

Karyotype (n = 28)

 

   Favorable

1

   Intermediate

10

   Unfavorable

17

Etiology of AML

 

   Primary

9

   Secondary

20

Stage of the disease

 

   Untreated (all secondary)

15

   Refractory

4

   Relapsed < 1 year

5

   Relapsed > 1 year

5

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us